Skip to Content


In the US, Droxidopa (droxidopa systemic) is a member of the drug class vasopressors and is used to treat Hypotension.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Treatment of Parkinson's disease

Chemical Name


Foreign Names

  • Droxidopa (Latin)
  • Droxidopa (German)
  • Droxidopa (French)
  • Droxidopa (Spanish)

Generic Names

  • Droxidopa (OS: JAN, USAN)
  • Droxidopa (PH: JP XVII)

Brand Names

  • Dops 20%
    Dainippon Sumitomo Pharma, Japan
  • Dops OD
    Dainippon Sumitomo Pharma, Japan
  • Droxidopa
    Kyowa Yakuhin, Japan; Mylan Seiyaku, Japan; Nichi-Iko Pharmaceutical, Japan
  • Droxidopa 20%
    Mylan Seiyaku, Japan
  • Northera
    Lundbeck, United States


JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.